Case Report: Recurrent supraglottitis in a patient with metastatic melanoma treated with ipilimumab and nivolumab
{{output}}
Background: Immune checkpoint inhibitors (ICIs) are a standard of care for advanced melanoma but have the potential to cause immune-related adverse events (irAEs), which can vary widely in character and severity. Immune-related a... ...
